Bradley D.

Bradley D. is a senior computational chemist at AstraZeneca with over five years of experience in integrating AI platforms and molecular modeling to enhance drug discovery processes. They have led multiple oncology programs, successfully accelerating project timelines and significantly improving compound development metrics. Previously, Bradley contributed to research at Photys Therapeutics and held positions as a graduate mentor and researcher at the University of Wisconsin-Madison. They earned a Ph.D. from the University of Wisconsin-Madison and a Bachelor of Science from the University of Utah. Passionate about merging computational innovation with therapeutic applications, Bradley has published in top-tier journals and received recognition for excellence in research.